Tips for: Solid Oral Dosage Forms

Powder blend homogeneity is a critical factor in ensuring consistent dissolution and bioavailability of pharmaceutical products, especially in solid dosage forms like tablets and capsules. High variability in the dissolution profile of a product can lead to inconsistent therapeutic effects, making it difficult to achieve reliable and predictable drug release. Poor homogeneity in powder blending can result from inadequate mixing of the active pharmaceutical ingredient (API) and excipients, leading to uneven distribution within the blend. This issue is especially prominent when formulating drugs with low dose-to-excipient ratios or drugs that exhibit poor flow properties.
Click to read the full article.

Formulating high-molecular-weight (HMW) active pharmaceutical ingredients (APIs), such as biologics, peptides, or certain nucleotides, presents unique challenges. These APIs are often poorly soluble in common solvents, and their compatibility with solvents can affect both the stability and bioavailability of the final dosage form. Incompatibility with solvents can lead to issues such as aggregation, precipitation, or denaturation of the API, making it difficult to achieve a stable, effective, and scalable formulation. Finding suitable solvents that can dissolve or stabilize HMW APIs without compromising their integrity is essential for successful drug development and commercialization.
Click to read the full article.

Capsules, particularly soft gelatin capsules, are often sensitive to environmental conditions such as humidity and temperature. Low humidity conditions can lead to an increase in capsule brittleness, which may result in breakage or deformation during storage, handling, or transport. This is especially problematic for products requiring a delicate formulation and those that must be handled gently to preserve their integrity. The brittleness of capsules under low humidity can also affect the dissolution and disintegration properties of the capsule, impacting the bioavailability and efficacy of the active pharmaceutical ingredient (API).
Click to read the full article.

Capsules are often preferred for pharmaceutical formulations due to their ease of swallowing, accurate dosing, and ability to mask unpleasant tastes or odors. However, maintaining capsule transparency, particularly in soft gelatin capsules, can present challenges. Transparent capsules offer visual appeal and can showcase the fill material, which is important for products where appearance plays a role in patient acceptance or branding. However, achieving and maintaining transparency in capsules, while ensuring the stability and efficacy of the fill material, can be difficult due to the limited availability of excipients that do not affect the capsule’s clarity.
Click to read the full article.

Probiotic formulations are essential for supporting gut health and immune function, and they are commonly delivered in capsule form. However, one of the major challenges in developing probiotic capsules is maintaining the stability of the live microorganisms throughout the product’s shelf life. Probiotics are sensitive to various environmental factors, including moisture, heat, light, and oxygen, which can degrade their potency and efficacy. Ensuring that probiotics remain viable and effective when encapsulated is critical for the success of the product and patient satisfaction.
Click to read the full article.

Combining controlled-release (CR) and immediate-release (IR) profiles within the same capsule is a complex challenge, particularly for drugs that require both rapid onset of action and sustained therapeutic effects. This combination approach is often required in conditions where rapid relief is needed initially, followed by a prolonged therapeutic effect over time. However, balancing the release profiles of both components while maintaining the stability, safety, and efficacy of the final product requires careful formulation development, excipient selection, and manufacturing control. Ensuring that the IR and CR components work together seamlessly is essential for achieving optimal therapeutic outcomes.
Click to read the full article.

Fast-dissolving capsules are critical for ensuring rapid onset of action for certain APIs, especially those used for conditions requiring immediate therapeutic effects. However, developing capsules that disintegrate and release their contents quickly can be challenging due to factors such as the physical properties of the capsule shell, the formulation of the fill material, and the manufacturing process. Achieving a fast dissolution rate without compromising the stability, safety, and efficacy of the product is essential for patient compliance and therapeutic success.
Click to read the full article.